AllerGen researchers have pinpointed a new gene associated with peanut allergy. The gene, c11orf30/EMSY, is already known to play a role in other allergy-related conditions, such as eczema, asthma, and allergic rhinitis. This study is the first to associate the …
AllerGen investigator Dr. Brett Finlay (The University of British Columbia) is one of six 2018 inductees to the Canadian Medical Hall of Fame. Laureates of this honour are individuals whose contributions to medicine and the health sciences have led to …
Dr. Brett Finlay inducted into Canadian Medical Hall of Fame Read more »
In 2014, AllerGen’s Clinical Investigator Collaborative (CIC) conducted an early Phase II clinical trial on the injectable biologic drug tezepelumab, developed by MedImmune (the biologics arm of AstraZeneca) and Amgen, and first identified the drug’s significant therapeutic potential. “Now, it’s …
CIC-tested biologic poised to become a “game-changing, blockbuster” asthma drug Read more »
On August 2, 2017, AllerGen investigator Dr. Meghan Azad (University of Manitoba) participated in a panel discussion organized by the CIHR’s Institute of Human Development, Child & Youth Health (IHDCYH) on breastfeeding and children’s health. In the event, Dr. Azad …
AllerGen researcher featured in CIHR breastfeeding panel Read more »
Autumn has brought change to the administrative ranks of the CHILD Study. As of September 1, 2017, the Manitoba site has a new Research Coordinator, and as of September 8, 2017, CHILD Toronto has a new Site Leader. Dr. Theo …
For years, scientists have attempted to understand the complexities of human milk—what it’s made of, how it’s produced, and how its unique composition affects an infant’s growth and development. In a new study published in the International Journal of Obesity, …
Breastmilk hormones may help prevent obesity in infants Read more »
Eating peanut while breastfeeding and early peanut introduction may help protect against peanut allergy in children, according to a new study led by researchers at the Children’s Hospital Research Institute of Manitoba and the University of Manitoba and published in …
Protecting against peanut allergy in children: new findings Read more »
With profound sadness, we confirm that Michelle Harkness, AllerGen’s Manager, Highly Qualified Personnel (HQP) Training and Events, and a longtime colleague and friend, passed away on August 22, 2017, following a brief illness. Michelle managed AllerGen’s HQP program with passion …
AllerGen investigators Drs Manel Jordana and Susan Waserman and AllerGen HQP Dr. Derek Chu have prepared a statement in response to a recent Australian study being heralded as a “breakthrough” and a “cure” for peanut allergy. The paper, published in …
Canadian allergists/immunologists comment on recent Australian oral immunotherapy study Read more »
AllerGen trainee Dr. Natalia Mykhaylova has been selected as one of six finalists in the Scientific and Technology Innovation category for the Lieutenant Governor’s Visionaries Prize. The prize was created to give Ontario’s most creative thinkers a platform for tackling …
AllergyAware.ca has won two Gold Omni Awards for website excellence in the categories of Education and Health & Fitness. AllergyAware.ca provides free access to online courses regarding anaphylaxis and allergy within the school environment, community and child care. The medically …
On August 11, 2017, student Benjamin Cruickshank and his mom, Allison, met with AllerGen staff to share how the Allergy Pals program for kids with food allergies has had an impact on their lives. “I love Allergy Pals,” says 11-year-old …